Previous Close | 226.12 |
Open | 226.59 |
Bid | 224.90 x 1200 |
Ask | 226.05 x 1000 |
Day's Range | 224.46 - 227.44 |
52 Week Range | 197.47 - 306.08 |
Volume | 2,242,187 |
Avg. Volume | 1,923,154 |
Market Cap | 58.652B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 22.10 |
EPS (TTM) | 10.20 |
Earnings Date | Jan 28, 2021 - Feb 01, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 285.58 |
To this end, The Boston Consulting Group (BCG) and Fortune magazine created the Fortune Future 50, "the global companies with the best prospects for future growth." The top five names on Fortune Future 50's list include ServiceNow (NOW), Veeva Systems (VEEV), Atlassian (TEAM), Workday (WDAY), and Splunk (SPLK). ServiceNow is an enterprise software company, focusing on digital workflows.
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $225.55, marking a -0.25% move from the previous day.
The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals